Biotech FAQs

Reset filter
July 2, 2025 FAQ

What makes in-vivo CAR therapies the next frontier in cell therapy?

Explore key questions and answers to learn how this innovative approach is transforming treatment possibilities. ...

Read More
June 12, 2025 FAQ

FAQs on Live Biotherapeutic Products

Live biotherapeutic products contain a single species or consortium of live microorganisms such as bacteria or yeast isolated from human...

Read More
April 22, 2025 FAQ

Overview of Obesity: Global Clinical Trials Landscape

Obesity is a chronic, progressive metabolic disease driven by excessive fat accumulation, increasing the risk of serious health conditions such...

Read More
April 10, 2025 FAQ

Overview of Idiopathic Pulmonary Fibrosis: Global Clinical Trials Landscape

Idiopathic Pulmonary Fibrosis is a highly infectious lung disease that can lead to chronic infection, cirrhosis, and cancer.&n...

Read More
March 26, 2025 FAQ

Regulatory Compliance in Clinical Research

Regulatory compliance in clinical research refers to adhering to laws, guidelines, and regulations established by governmental and international bodies to...

Read More
March 24, 2025 FAQ

Importance of Patient Recruitment in Clinical Trials

Patient recruitment is essential in clinical trials because the success of a trial largely depends on the participation of suitable...

Read More
March 24, 2025 FAQ

The Role of CROs in Drug Development

A Contract Research Organization (CRO) is a service organization that provides support to the pharmaceutical, biotechnology, and medical device industries...

Read More
March 24, 2025 FAQ

How to Choose the Right CRO for Your Clinical Trial

1. What factors should be considered when choosing a CRO for a clinical trial?When selecting a CRO for a clinical...

Read More
March 24, 2025 FAQ

FAQ on the Clinical Trial Process

1. What is a clinical trial?A clinical trial is a research study that tests the safety and effectiveness of new...

Read More
March 24, 2025 FAQ

FAQs: The Early Phase Australian Advantage for Biotech Companies

Australia offers a rare combination of regulatory efficiency, cost savings, high-quality clinical infrastructure, and global data acceptance, making it an...

Read More
March 19, 2025 FAQ

FAQs on the siRNA Therapeutics

1. What are siRNA therapeutics, and how do they work?siRNA therapeutics belong to a class of gene-silencing drugs that utilize...

Read More
March 10, 2025 FAQ

FAQs on Infectious Diseases: Insights into Clinical Trial Landscape and Industry Trends

Gaining insights into the rapidly evolving infectious disease clinical trial landscape is essential for researchers, biotech firms, and industry stakeholders....

Read More
February 27, 2025 FAQ

Overview of Hepatitis B: Global Clinical Trials Landscape

Hepatitis B is a highly infectious liver disease that can lead to chronic infection, cirrhosis, and cancer....

Read More
January 8, 2025 FAQ

FAQs on the Oncolytic Virus Therapy: Insights into Clinical Trial Landscape and Industry Trends

Explore our comprehensive FAQs addressing critical aspects of oncolytic virus therapy, including clinical trial trends, therapeutic advancements, delivery innovations, and...

Read More
January 7, 2025 FAQ

Overview of Triple-Negative Breast Cancer: Global Clinical Trial Landscape

Triple-Negative Breast Cancer (TNBC) is a highly aggressive and heterogeneous subtype of breast cancer ...

Read More
December 12, 2024 FAQ

Overview of Parkinson’s disease: Global Clinical Trials Landscape

Parkinson's disease is the second most common neurodegenerative disorder....

Read More
December 3, 2024 FAQ

Overview of COVID-19: Global Clinical Trial Landscape

COVID-19, caused by the SARS-CoV-2 virus, is a highly transmissible and severe infectious disease that has led to a global...

Read More
November 18, 2024 FAQ

FAQs on the Global Vaccine Clinical Trial Landscape

Your Questions Answered: Prophylactic vs. Therapeutic Trials, Regional Insights, and Technological Advancements...

Read More
October 24, 2024 FAQ

Overview of Bladder Cancer: Global Clinical Trials Landscape

Bladder cancer is the ninth most common cancer globally and ranks thirteenth in mortality....

Read More
October 2, 2024 FAQ

Overview of Diffuse large B-cell lymphoma: Global Clinical Trial Landscape

Diffuse large B-cell lymphoma is the most common and aggressive subtype of non-Hodgkin lymphoma....

Read More
October 1, 2024 FAQ

Overview of Small Cell Lung Cancer: Global Clinical Trials Landscape

Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung...

Read More
September 27, 2024 FAQ

Cell and Gene Therapies – Global Clinical Trials Landscape (2024)

A comprehensive list of Frequently Asked Questions (FAQ) on Cell and Gene Therapies: Insights into Clinical Trial Landscape and Industry...

Read More
September 27, 2024 FAQ

Cervical Cancer– Global Clinical Trials Landscape (2024)

Comprehensive Frequently Asked Questions on cervical cancer: Insights into Clinical Trial Landscape and Industry Trends....

Read More
September 4, 2024 FAQ

Overview of Gastric Cancer: Global Clinical Trial Landscape

Gastric cancer ranks as the fifth most diagnosed cancer and the leading cause of cancer-related deaths....

Read More
September 4, 2024 FAQ

Overview Of Pancreatic Cancer: Global Clinical Trials Landscape

Pancreatic cancer is one of the deadliest gastrointestinal cancers, ranking twelfth in global incidence and sixth in cancer-related deaths....

Read More
August 15, 2024 FAQ

RNA Therapies – Global Clinical Trials Landscape (2024)

Comprehensive FAQs on RNA Therapies: Insights into Clinical Trials Landscape and Industry Trends...

Read More
July 18, 2024 FAQ

Overview of Oesophageal cancer: Global Clinical Trials Landscape

Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer mortality. It starts in the...

Read More
July 10, 2024 FAQ

Insights into Chronic Lymphocytic Leukemia: Global Clinical Research Overview

Chronic Lymphocytic Leukemia (CLL) is slow-growing leukemia characterized by a progressive accumulation of functionally impaired B lymphocytes of monoclonal origin....

Read More
June 26, 2024 FAQ

Insights into Non-Small Cell Lung Cancer: Global Clinical Research Overview

Non-small cell lung cancer (NSCLC), which constitutes about 85% of all lung cancers originates from larger cells, such as the...

Read More
June 19, 2024 FAQ

Insights into Radiopharmaceuticals: Global Clinical Research Overview

Explore key insights and emerging trends in the field of radiopharmaceuticals from our 2024 clinical trial landscape white paper, answering...

Read More
June 19, 2024 FAQ

Overview of Liver Cancer: Global Clinical Trials Landscape

Liver cancer is the sixth most diagnosed cancer globally and the third leading cause of cancer death....

Read More
May 24, 2024 FAQ

Insights into Epilepsy: Global Clinical Research Overview

Epilepsy is a chronic neurological disorder causing recurrent seizures due to various factors like structural, genetic, viral, metabolic, and immunological...

Read More
May 21, 2024 FAQ

Unveiling the Potential of Antibody-Drug Conjugates

This FAQ section explores key trends in clinical trials, applications, and cutting-edge research shaping the future of these targeted therapies....

Read More
May 15, 2024 FAQ

Overview of Endometrial cancer: Global Clinical Trials Landscape

Uterine cancer, primarily endometrial cancer, ranks as the fourth leading cause of global gynecological malignancy-related deaths....

Read More
March 26, 2024 FAQ

Insights into the Clinical Trials Landscape of Cystic Fibrosis

Cystic Fibrosis, a genetic disorder, disrupts chloride and bicarbonate transport, causing thick mucus accumulation in organs like the lungs and...

Read More
March 26, 2024 FAQ

Global Prevalence and Clinical Trials Landscape of Acute Myeloid Leukaemia

Acute Myeloid Leukaemia is a malignant blood disorder primarily affecting adults, with low survival rates and various risk factors including...

Read More
March 12, 2024 FAQ

Investigating Global Clinical Research Perspectives in Precision Oncology

1....

Read More
February 22, 2024 FAQ

Global Prevalence and Clinical Trials Landscape of Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy, a rare genetic disorder, is primarily attributed to a deficiency in the dystrophin protein, essential for muscle...

Read More
February 1, 2024 FAQ

Exploring Global Clinical Research Perspectives on Rheumatoid Arthritis Insights

Rheumatoid Arthritis (RA) is a global health concern, affecting 17.6 million people globally. Regional variations are evident, with East and...

Read More
February 1, 2024 FAQ

Insights into Candidiasis: Global Clinical Research Overview

1. What is the global prevalence of Candidiasis, and how does it impact different regions and demographics?   Candidiasis, caused by Candida,...

Read More
January 25, 2024 FAQ

Global Strides in HIV Research: Mapping the Clinical Trial Terrain

Introduction:In the dynamic realm of HIV research, treatment, and prevention, significant strides are continuously being made....

Read More
November 29, 2023 FAQ

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy

The landscape of cancer treatment has witnessed a revolutionary transformation with the advent of immune checkpoint inhibitors (ICIs), marking a...

Read More
November 28, 2023 FAQ

Metastatic Breast Cancer: Navigating the Global Landscape of Challenges and Success in Clinical Trials

1....

Read More
November 13, 2023 FAQ

From Financial Challenges to Innovations: The Unfolding Story of the Biotech Sectors in 2023

In 2023, the biotech sectors faced a significant transformation, witnessing layoffs and workforce reductions, particularly impacting smaller enterprises. Economic pressures,...

Read More
November 8, 2023 FAQ

Navigating Dyslipidaemia: Global Prevalence, Treatment Approaches, and Clinical Trials

Dyslipidaemia, a condition marked by abnormal blood lipid levels, poses a significant global health challenge, notably contributing to the risk...

Read More
November 6, 2023 FAQ

Exploring the Global Landscape of Non-Small Cell Lung Cancer (NSCLC) Research

The global landscape of clinical trials for non-small cell lung cancer is evolving with contributions from diverse regions, crucial for...

Read More
October 26, 2023 FAQ

Navigating the Landscape of CAR-T Research in China

This FAQ delves into the promising trends and developments in CAR-T Research in China....

Read More
October 12, 2023 FAQ

Navigating the Landscape of Infectious Diseases Clinical Research in 2023

This FAQ delves into the promising trends and developments in Infectious Diseases research....

Read More
October 12, 2023 FAQ

Navigating the Landscape of Hemophilia Clinical Research in 2023

This FAQ delves into the promising trends and developments in Hemophilia research....

Read More
October 10, 2023 FAQ

Navigating the Landscape of Primary Biliary Cholangitis (PBC) Clinical Research in 2023

This FAQ delves into the promising trends and developments in Biliary Cholangitis (PBC) research....

Read More
September 13, 2023 FAQ

Rare Disease Clinical Trials: Unveiling Insights and Charting Progress

A rare disease, as defined by the WHO, is one that affects fewer than one person in every 1,000 and...

Read More
September 13, 2023 FAQ

Unlocking the Future of Healthcare: Exploring Global Clinical Trends in Cell & Gene Therapy

Cell and gene therapy (CGT) is one of the most advanced areas of medicine that can effectively transform our own...

Read More
September 1, 2023 FAQ

Nasopharyngeal Carcinoma: Unveiling Facts, Statistics, and Clinical Research Developments

NPC originates in the nasopharynx, the upper part of the throat, just behind the nose and is primarily found primarily...

Read More
August 28, 2023 FAQ

Advancing Treatment of Gallbladder Cancer (GBC): Clinical Trials, New Drugs, and Innovative Strategies

GBC presents unique challenges due to its often-advanced stage at diagnosis....

Read More
August 24, 2023 FAQ

An In-Depth Analysis of CRO Operations and Impact on Drug Development

What does a CRO do? CROs are recognized as strategic partners for sponsors seeking to manage and conduct clinical trials efficiently....

Read More
August 10, 2023 FAQ

The Future of Clinical Trials: Embracing Virtualization, Real-World Evidence, and AI Integration

The clinical trial landscape is constantly evolving....

Read More
November 16, 2022 FAQ

Clinical Data Management: Past, Present and Future

Clinical Data Management (CDM) is an integral part of clinical trials and enables clinical trial staff to extract valuable, accurate,...

Read More
November 11, 2022 FAQ

Types of Clinical Data Management

Clinical Data Management (CDM) deals specifically with the information that is collected during the clinical trial....

Read More
October 31, 2022 FAQ

Contract Research Organisations and the Different Roles They Play

A Contract Research Organisation (CRO) provides research services to the biotechnology, pharmaceutical and medical device industries through a contract agreement....

Read More
October 27, 2022 FAQ

Contract Research Organisations: Market and Trends

The Contract Research Organisation (CRO) industry is constantly changing and growing due to various key factors like a growing healthcare...

Read More
October 20, 2022 FAQ

The Future of Contract Research Organisations

Contact Research Organisations (CROs) have undergone many changes over the past few years, thanks to the COVID-19 pandemic and technological...

Read More
September 30, 2022 FAQ

Bioinformatics

Bioinformatics is the scientific discipline that includes the use of computers to collect, store and analyse information relating to biological...

Read More
September 21, 2022 FAQ

DNA and RNA

DNA (Deoxyribonucleic Acid) is the genetic material found inside cells responsible for a living organism's development and function....

Read More
September 12, 2022 FAQ

Pharmacogenomics

Pharmacogenomics is the study of how a person’s DNA responds to drugs....

Read More
August 26, 2022 FAQ

Biosafety

According to the World Health Organisation (WHO): “Biosafety is a strategic and integrated approach to analysing and managing rel...

Read More
August 22, 2022 FAQ

Bioprospecting and Biopiracy

Bioprospecting is the search for and the commercialisation of new products that have been sourced from nature....

Read More
July 29, 2022 FAQ

Biobanks and Biotechnology

Biobanks are storage facilities that house blood samples, DNA, tissue samples and tumour cells that are used for research purposes....

Read More
April 1, 2022 FAQ

Clinical Trends of 2022

2022 marks the third year of the worldwide COVID-19 pandemic, which continues to fuel the transformation of the clinical trial...

Read More
March 2, 2022 FAQ

What is the Driving Force Behind China’s Biotech Revolution?

In 2011, China stated that its biomedicine industry was one of seven strategic priorities, and in its Five-Year Plan (2015-2020),...

Read More
February 7, 2022 FAQ

Clinical Development Strategies for Western Biotech Companies in China

Since 2015, the medical and research industries in China have seen a huge shift with their regulatory processes and framework,...

Read More
October 29, 2021 FAQ

Virtual Clinical Trials in Asia and Australia

The COVID-19 pandemic has had an impact on clinical trials around the world with the research and medical industry having...

Read More
October 18, 2021 FAQ

Monitoring Participants in a Virtual Clinical Trial

Monitoring is a crucial element of any clinical trial, with The National...

Read More
October 18, 2021 FAQ

The Challenges and Opportunities of Virtual Clinical Trials

Virtual Clinical Trials (also known as Decentralised Trials and Siteless Trials) bring clinical trials directly into the participant’s home via...

Read More
October 8, 2021 FAQ

What is an Investigator Site File (ISF)?

An Investigator Site File (ISF) contains essential documents which shows that the clinical trial site and Investigator are following the...

Read More
October 8, 2021 FAQ

Corrective and Preventive Action

CAPA (Corrective and Preventive Action) is a quality system plan which aims to resolve compliance issues and to prevent any...

Read More
August 13, 2021 FAQ

Data Monitoring Committee

Data Monitoring Committees (DMCs) also known as Data Safety Monitoring Boards (DSMBs) and Data Monitoring and Ethics Committee (DMEC) play...

Read More
August 13, 2021 FAQ

Reporting Serious Breaches in Clinical Trials

A ‘Serious Breach’ is defined as being a breach of Good Clinical Practice or clinical trial protocol which has an...

Read More
July 28, 2021 FAQ

What is an Investigator’s Brochure?

An Investigator’s Brochure is a collection of clinical and non-clinical data about the investigational products that are the focus of...

Read More
July 28, 2021 FAQ

Randomisation in Clinical Trials

The Use of Randomisation in Clinical Trials  Randomisation Controlled Trials (RCT) is the process of randomly assigning participants to groups that...

Read More
June 10, 2021 FAQ

What is a Trial Master File? (TMF)

A Trial Master File (TMF) is a compilation of documents that prove that the clinical trial has been conducted following...

Read More
June 3, 2021 FAQ

What is a Case Report Form?

A Case Report Form (CRF) is an electronic or paper document which is used in a clinical trial to record...

Read More
April 30, 2021 FAQ

Data Management in Clinical Trials

Clinical Data Management (CDM) is the process of putting together, handling, collecting and analysis of clinical data, which is done...

Read More
March 29, 2021 FAQ

The importance of control groups in clinical trials

A control group refers to a group of clinical trial participants who do not receive the drug or treatment being...

Read More
March 24, 2021 FAQ

What makes a Good Clinical Trial Site

The site selection is crucial to the outcome of a clinical trial; it has the power to either make or...

Read More
March 17, 2021 FAQ

Good Clinical Practices

Good Clinical Practice (GCP) is defined as being an “internationally accepted standard for the designing, conducting, recording and reporting of...

Read More
February 25, 2021 FAQ

How to Recruit Participants and How Participants can Take Part

One of the most important and challenging parts of a clinical trial is finding participants who are willing to volunteer...

Read More
February 18, 2021 FAQ

Placebos: Why They Play an Important Role in Clinical Trials

Placebos are used to form a comparison point for new treatments, so the medication being tested can be deemed safe...

Read More
January 15, 2021 FAQ

Benefits of running clinical trials in Australia

Australia has the reputation of being home to a world-class research infrastructure with renowned health professionals and researchers overseeing clinical...

Read More
December 14, 2020 FAQ

Glossary of Important Terms Related to Clinical Trials

The following list are common terms that are often associated with clinical research and trials....

Read More
September 10, 2020 FAQ

Ensuring clinical trial participant safety

The safety of clinical trial participants is of paramount importance to CRO companies....

Read More
September 9, 2020 FAQ

How to Understand the Structure of CRO Companies

CRO (Contract Research Organization) companies can vary in size from global companies to small specialized groups....

Read More
July 29, 2020 FAQ

How CRO Companies Work? - A Basic Overview

It’s quite common for pharmaceutical and biotechnology companies introducing new drugs and treatment to outsource trials of new medication or...

Read More
July 29, 2020 FAQ

How Long It Takes a CRO Company to Complete a Clinical Trial?

Before any new medication or treatment can be administered to patients, it needs to undergo several clinical trial Phases which...

Read More
July 29, 2020 FAQ

How to choose a CRO Company for Clinical Research?

Selecting a reliable CRO clinical Research Company is crucial to the success of a clinical trial and pharma companies need...

Read More